GEA opens factory in India

Published: 23-Mar-2010
Manufacturing

Vadodara, Gujarat factory provides local build of processing equipment

GEA Pharma Systems has opened a new factory in Vadodara, Gujarat to service India and provide reduced-cost manufacturing of high-technology solid dose and liquid pharmaceutical processing equipment for the local market. The company will initially manufacture fluid bed and granulation technology in the new facility and will extend the scope of production to meet growing demand.

Until now GEA Pharma Systems, the technology leader in pharmaceutical processing, has manufactured outside India, mainly in Europe. The new factory will offer strategic low-cost manufacturing, allowing the company to provide European-quality processing equipment at prices that are affordable in the growing Indian market.

‘India is a high-growth market that’s very price-sensitive and susceptible to technology,’ said Navin Lakhanpaul, regional manager for GEA Pharma Systems in Vadodara. ‘This low-cost manufacturing base will allow us to provide the high-end, European quality products our Indian customers need at prices that are appropriate to the local market.’ He added that the local manufacture will also help the company be more reactive to local market demands.

The factory will employ local staff and peripheral equipment, such as control systems, will also be sourced locally, providing an additional boost to local suppliers. ‘In most projects, much of the project value is in peripheral equipment. It’s also essential for us to keep the technical know-how close at hand to help us maintain the efficient after-sales service our customers expect,’ said Navin.

The effects of low-cost manufacturing, locally-sourced peripheral equipment and reduced transportation costs can often reduce the equipment price significantly when compared with equipment bought from Europe.

Navin also explained that the high quality approach satisfied the demand for all pharmaceutical equipment produced in India to meet international quality standards. ‘Not only do our Indian customers want to supply the local market with high-quality products they also want the facilities necessary to sell into Europe and offer manufacturing services to European customers. Our equipment provides the necessary quality, efficiency and environmental control to allow them to do so.’

Frans Maas, GEA Pharma Systems’ division director for sales and marketing, commented that the new facility was critical to the organisation’s long-term plans. ‘The factory in Vadodora is an important development for our company and part of our strategy for sustainable supply,’ he explained. The opening of the factory, for example, follows soon after GEA’s announcement of two agency agreements with ACE Technologies of Mumbai, for the distribution of MODUL tablet presses from GEA Courtoy and pharmaceutical freeze drying technology from GEA Lyophil throughout India.

The factory has been built adjacent to the company’s existing office building which was opened in 2007.
See more

You may also like

Manufacturing

Abzena named a leader in Frost & Sullivan ADC CDMO radar report

Read more
Recognition highlights integrated capabilities, proprietary technology and expertise in antibody-drug conjugates

Trending Articles

  1. Lyocontract invests €50m in new freeze-drying facility with Syntegon vial line German CDMO Lyocontract has begun construction of a €50m expansion in Ilsenburg, partnering with Syntegon to install a complete vial filling and lyophilisation line for sterile freeze-dried pharmaceuticals
  2. Why weight sorting should move earlier in OSD development Phillip Ruda explains how earlier weight intelligence can improve process understanding, reduce risk and accelerate learning cycles
  3. Piramal Pharma Solutions’ Grangemouth facility successfully delivers 1500th ADC batch With this achievement, Piramal strengthens its leadership position in delivering critical bioconjugate therapies to patients in need
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Moving with speed and scale: innovative, material-sparing approaches to accelerate clinical development As early-stage drug development is often hindered by limited API supply, rising costs and tight timelines, material-sparing technologies are helping companies to progress faster with less
  5. Viatris to cut 10% of its global workforce after Indian plant fire Viatris has lowered its profit outlook for 2026 after a fire in February shut down a key plant in Nashik, India. Despite this, the company reported stronger-than-expected revenue and announced a restructuring plan

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Manufacturing

Abzena named a leader in Frost & Sullivan ADC CDMO radar report

Recognition highlights integrated capabilities, proprietary technology and expertise in antibody-drug conjugates
Manufacturing

LabVantage Solutions introduces LabVantage CORTEX, advancing its LIMS platform for AI-driven laboratory operations

Next-Generation Platform Extends LIMS with Agentic AI and Cloud-Native Automation to Improve Efficiency, Reduce Errors and Gain Deeper Insight from Data. Learn More from LabVantage Leadership at Pittcon 2026
Manufacturing

Schütz to build automated IBC production facility at BASF's Ludwigshafen headquarters

Packaging specialist Schütz has signed an agreement with BASF to construct a highly automated intermediate bulk container manufacturing and storage facility directly adjacent to the chemical giant's main plant in Ludwigshafen, enabling round-the-clock just-in-time delivery
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

LGM Pharma announces $9 million investment into Colorado and Texas manufacturing facilities

The investment marks the second phase of the the company's expansion, funding facility upgrades to increase capacity for suppository, semi-solid and oral solid dose and differentiating LGM in the US CDMO market, says CEO Prasad Raje, speaking exclusively to Manufacturing Chemist
Manufacturing

SGD Pharma partners with Prince Sterilisation Services for pharmaceutical glass packaging

The pair have already launched the My Sterinity Nasal platform, a new, versatile sterile vial range within SGD Pharma's My Sterinity RTU platform, using the company's U-Save Type I vials, which are designed to support the growing segment of high-value nasal drug delivery
Manufacturing

Pope Scientific - Finding solutions since 1963

Pope Scientific have been designing and manufacturing distillation and filtration equipment for laboratories, pilot plants, and production processing worldwide for over 60 years
Manufacturing

Piramal Pharma Solutions’ Grangemouth facility successfully delivers 1500th ADC batch

With this achievement, Piramal strengthens its leadership position in delivering critical bioconjugate therapies to patients in need
Subscribe now